Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ripasudil free base

Copy Product Info
😃Good
Catalog No. T7492Cas No. 223645-67-8
Alias K-115 (free base)

Ripasudil free base (K-115 (free base)) is a selective and potent ROCK inhibitor, is a novel and potent antiglaucoma agent.

Ripasudil free base

Ripasudil free base

Copy Product Info
😃Good
Catalog No. T7492Alias K-115 (free base)Cas No. 223645-67-8
Ripasudil free base (K-115 (free base)) is a selective and potent ROCK inhibitor, is a novel and potent antiglaucoma agent.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$73InquiryInquiry
5 mg$162InquiryInquiry
10 mg$264InquiryInquiry
25 mg$588InquiryInquiry
50 mg$970InquiryInquiry
100 mg$1,622InquiryInquiry
1 mL x 10 mM (in DMSO)$178InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Ripasudil free base (K-115 (free base)) is a selective and potent ROCK inhibitor, is a novel and potent antiglaucoma agent.
Targets&IC50
CaMK IIa:370 nM, ROCK1:51 nM, ROCK2:19 nM, PKC:27 μM, PKACa:2.1 μM
In vitro
Ripasudil significantly reduced infiltrating cells and protein exudation in the aqueous humor, as well as the number of infiltrating cells in the ICB and adherent leukocytes in retinal vessels in EIU. Additionally, the protein level of MCP-1 in the aqueous humor and mRNA levels of IL-1β, IL-6, TNF-α, MCP-1, and intercellular adhesion molecule-1 in the ICB and retina were suppressed by ripasudil. The production of MCP-1 and nuclear translocation of NF-κB in RAW264.7 cells were also suppressed by ripasudil[1].
In vivo
Ripasudil had selective and potent inhibitory effects on ROCKs.In rabbits, topical instillation of Ripasudil significantly reduced IOP in a dose-dependent manner.Maximum IOP reduction was observed 1 h after topical instillation, which was 8.55 ± 1.09 mmHg (mean ± SE) from the baseline IOP at 0.5%.In monkeys, maximum IOP reduction was observed 2 h after topical instillation, which was 4.36 ± 0.32 mmHg from the baseline IOP at 0.4%, and was significantly stronger than that of 0.005% latanoprost.Whole-head autoradiography showed that the radioactivity level was maximum at 15 min after instillation of [(14)C]Ripasudil in the ipsilateral eye.Single instillation of 0.4% Ripasudil showed no effect on aqueous flow rate or uveoscleral ouTheaflavinlow, but significantly increased conventional ouTheaflavinlow facility by 2.2-fold compared to vehicle-treated eyes in rabbits[2].
Cell Research
Endotoxin-induced uveitis was induced by footpad injection of lipopolysaccharide (LPS). Ripasudil was administered intraperitoneally 1 hour before and after LPS injection. The aqueous humor was collected 24 hours after injection, and the infiltrating cells, protein concentration, and levels of monocyte chemotactic protein-1 (MCP-1) were determined. Infiltrating cells in the iris ciliary body (ICB) and adherent leukocytes in retinal vessels were evaluated. The mRNA levels of IL-1β, IL-6, TNF-α, and MCP-1 in the retina and ICB were determined. A mouse macrophage cell line, RAW264.7, was stimulated with LPS in the presence or absence of ripasudil, and the expression of MCP-1 and nuclear translocation of nuclear factor (NF)-κB was analyzed[1].
Animal Research
Kinase inhibition by K-115 was measured by biochemical assay.?IOP was monitored using a pneumatonometer in albino rabbits and monkeys after topical instillation of K-115.?The ocular distribution of [(14)C]K-115 was determined by whole-head autoradiography.?The aqueous flow rate was determined by fluorophotometry.?The total outflow facility and uveoscleral outflow were measured by two-level constant pressure perfusion and perfusion technique using fluorescein isothiocyanate-dextran, respectively[2].
SynonymsK-115 (free base)
Chemical Properties
Molecular Weight323.39
FormulaC15H18FN3O2S
Cas No.223645-67-8
SmilesC[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12
Relative Density.1.293 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ripasudil free base | purchase Ripasudil free base | Ripasudil free base cost | order Ripasudil free base | Ripasudil free base chemical structure | Ripasudil free base in vivo | Ripasudil free base in vitro | Ripasudil free base formula | Ripasudil free base molecular weight